Fingerprint
Dive into the research topics of 'Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Natasha B. Leighl, Matthew D. Hellmann, Rina Hui, Enric Carcereny, Enriqueta Felip, Myung Ju Ahn, Joseph Paul Eder, Ani S. Balmanoukian, Charu Aggarwal, Leora Horn, Amita Patnaik, Matthew Gubens, Suresh S. Ramalingam, Gregory M. Lubiniecki, Jin Zhang, Bilal Piperdi, Edward B. Garon
Research output: Contribution to journal › Article › peer-review